medigraphic.com
ENGLISH

Annals of Hepatology

Órgano Oficial de la Asociación Mexicana de Hepatología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2017, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (1)


High Clinical Manifestation Rate in an Imported Outbreak of Hepatitis E Genotype 1 Infection in a German Group of Travellers Returning from India

Pischke S, Schulze-zur-Wiesch J, Lütgehetmann M, Kreuels B, Lueth S, Kapaun P, Benten D, Schmiedel S, Sterneck M, Lohse AW, Polywka S
Texto completo Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 17
Paginas: 57-62
Archivo PDF: 153.60 Kb.


PALABRAS CLAVE

Sin palabras Clave

RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis 2010 51: 328-34. Doi: 10.1086/ 653943.

  2. Pischke S, Wedemeyer H. Hepatitis E virus infection: multiple faces of an underestimated problem. J Hepatol 2013; 58: 1045-6. Doi: 10.1016/j.jhep.2012.12.013.

  3. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55: 988-97. Doi: 10.1002/ hep.25505.

  4. Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany—an under-reported infectious disease. Dtsch Arztebl Int 2014; 111: 577-83. Doi: 10.3238/arztebl.2014.0577.

  5. Dalton HR, Bendall RP, Rashid M, Ellis V, Ali R, Ramnarace R, Stableforth WE, et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol 2011; 23: 1200-5. Doi: 10.1097/MEG.0b013e32834ca4da.

  6. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy IT, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384: 1766-73. Doi: 10.1016/S0140- 6736(14)61034-5.

  7. Garson JA, Ferns RB, Grant PR, Ijaz S, Nastouli E, Szypulska R, Tedder RD. Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results. J Virol Methods 2012; 186: 157-60. Doi: 10.1016/j.jviromet.2012.07.027.

  8. Zhai L, Dai X, Meng J. Hepatitis E virus genotyping based on full-length genome and partial genomic regions. Virus Res 2006; 120: 57-69. Doi: 10.1016/j.virusres.2006.01.013.

  9. Smith DB, Simmonds P, Izopet J, Oliveira-Filho EF, Ulrich RG, Johne R, Koenig M, et al. Proposed reference sequences for Hepatitis E virus subtypes. J Gen Virol 2016. Doi: 10.1099/ jgv.0.000393.

  10. Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, et al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J Hepatol 2016. Doi: 10.1016/j.jhep.2016.01.011.

  11. Gupta E, Pandey P, Pandey S, Sharma MK, Sarin SK. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. J Clin Virol 2013; 58: 374-7. Doi: 10.1016/j.jcv.2013.07.019.

  12. Wedemeyer H, Pischke S. Hepatitis: Hepatitis E vaccination— is HEV 239 the breakthrough? Nat Rev Gastroenterol Hepatol 2011; 8: 8-10. Doi: 10.1038/nrgastro.2010.207.

  13. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double- blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902. Doi: 10.1016/S0140-6736(10)61030-6.

  14. Shata MT, Navaneethan U. The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus? Clin Infect Dis 2008; 47: 1032-4. Doi: 10.1086/591971.

  15. Said B, Ijaz S, Kafatos G, Booth L, Thomas HL, Walsh A, Ramsay M, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15: 1738-44. Doi: 10.3201/eid1511.091094.

  16. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013; 207: 497-500. Doi: 10.1093/infdis/jis688.

  17. Pischke S, Polywka S, Haag F, Iking-Konert C, Sterneck M, Lütgehetmann M, Dammermann W, et al. Association of hepatitis E virus and essential cryoglobulinemia? J Clin Virol 2015; 67: 23-4. Doi: 10.1016/j.jcv.2015.03. 020.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ann Hepatol. 2017;16

ARTíCULOS SIMILARES

CARGANDO ...